請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35662完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 簡國龍 | |
| dc.contributor.author | Yu-Huei Huang | en |
| dc.contributor.author | 黃毓惠 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:03:39Z | - |
| dc.date.available | 2014-10-03 | |
| dc.date.copyright | 2011-10-03 | |
| dc.date.issued | 2011 | |
| dc.date.submitted | 2011-07-22 | |
| dc.identifier.citation | 1. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-73.
2. Fortune D, Richards H, Griffiths C et al. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157-74. 3. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-4. 4. Davidovici BB, Sattar N, Jorg PC et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-96. 5. Gelfand JM, Troxel AB, Lewis JD et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-9. 6. Abuabara K, Azfar RS, Shin DB et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J of Dermatol 2010; 163: 586-92. 7.Stern RS, Huibregtse A. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol 2011. 8. Zimmerman GM. Alcohol and psoriasis: a double burden. Arch Dermatol 1999; 135: 1541-2. 9. Sommer D, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2007; 298: 321-8. 10. Chang Y, Chen T, Liu P et al. Epidemiological study of psoriasis in the National Health Insurance Database in Taiwan. Acta Dermatol Venereol 2009; 89: 262-6. 11. Lin H, Wang K, Lin H. Increased risk of acute myocardial infarction in patients with psoriasis: A 5-year population-based study in Taiwan. J Am Acad Dermatol 2011; 64: 495-501. 12. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35. 13. Cohen AD, Gilutz H, Henkin Y et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007; 87: 506-9. 14. Huerta C, Rivero E, Rodriguez LAG. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65. 15. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-7. 16. Huang YH, Yang LC, Hui R-Y et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol 2010; 24: 1035-9. 17. Cohen AD, Dreiher J, Shapiro Y et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 2008; 22: 585-9. 18. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-34. 19. Cohen AD, Sherf M, Vidavsky L et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatol 2008; 216: 152-5. 20. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41. 21. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-6. 22. Wakkee M, Herings RMC, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010; 130: 962-7. 23. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-11. 24. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes & Immun 2007; 8: 1-12. 25. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients.[Erratum appears in J Invest Dermatol 1989 Feb;92(2):300]. J Invest Dermatol 1988; 91: 197-201. 26. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999; 135: 1490-3. 27. Prodanovich S, Kirsner RS, Kravetz JD et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3. 28. Pariser DM, Bagel J, Gelfand JM et al. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 2007; 143: 239-42. 29. Cox DR. Regression models and life tables (with discussion). J Royal Stat Society, series B. 1972; 34: 145-53. 30. Abeysekera W, Sooriyarachchi M. Use of Schoenfeld's global test to test the proportional hazards assumption in the Cox proportional hazards model: an application to a clncial study. J Natn Sci Foundation Sri Lanka 2009; 37: 41-51. 31. Gichangi A, Vach W. The analysis of competing risks data: a guided tour. Statist Med 2005; 19: 1753-69. 32. Fine J, Gary R. A proportional hazards model for subdistribution of a competing risk. J Am Stat Associa 1999; 94: 496-509. 33. Brauchli YB, Jick SS, Miret M et al. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. Journal of Investigative Dermatology 2009; 129: 2604-12. 34. Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117: 1531-7. 35. Singh N, Prakash A, Kubba S. Psoriatic nephropathy-does an entity exist? Ren Fail 2005; 27: 123-7. 36. Lai MN, Wang SM, Chen PC et al. Population-based case–control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Nati Cancer Inst 2010; 102: 179-86. 37. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225-30. 38. Federman DG, Shelling M, Prodanovich S. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 2009; 160: 1-7. 39. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. The inflammatory response in mild and in severe psoriasis Br J Dermatol 2004; 150: 917-28. 40. Kemeny M, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: A stepwise progression. Brain, Behav Immun 2007; 21: 1009-18. 41. Prodanowich S, Ma F, Taylor JR et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005; 52: 262-7. 42. Dixon WG, Watson KD, Lunt M et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007; 56: 2905-12. 43. Sattar N, Crompton P, Cherry L et al. Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study. Arthritis Rheuma 2007; 56: 831-9. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35662 | - |
| dc.description.abstract | 乾癬是一個慢性發炎性疾病,影響台灣0.19%的人口。乾癬患者除了生活品質不佳,可能合併憂鬱及焦慮等心理症狀。目前也知道,乾癬患者有比較高的風險會合併肥胖、糖尿病、心臟血管疾病及癌症。除此之外,乾癬患者有比較高的比例有喝酒及抽菸的習慣。這些都可能讓乾癬患者死亡的風險提高。從目前關於乾癬和死亡的研究結果來看,無論是大型全國性的世代研究,或是小型以醫院為主的世代研究都顯示出,乾癬的死亡風險升高,而心臟血管疾病、癌症、肝臟疾病、糖尿病和腎臟病都是它可能的特殊死因。
本研究是針對台灣一醫學中心的乾癬患者所作的。總共收集5490位20歲以上,65歲以下的乾癬患者,計算乾癬世代和全國人口比較的全死因和個別死因標準化死亡比,來看乾癬患者和全國人口比較後的死亡風險。另外,我們也調整了和死亡相關的風險因子包括年齡、性別和共同疾病,想探討嚴重型乾癬是否為死亡的風險因子。 由我們的研究結果發現,乾癬患者的全死因死亡率和全國人口比較起來是升高的(SMR:1.55,95%CI:1.35-1.77);而在特殊死因的部分,因為糖尿病(SMR:2.32,95%CI:1.46-3.68)、心臟血管疾病(SMR:2.20,95%CI:1.48-3.29)、肝臟疾病(SMR:2.74,95%CI:1.85-4.05)、癌症(SMR:1.34,95%CI:1.05-1.73)及腎臟疾病(3.30,95%CI:1.77-6.13)等原因而死亡的風險,都比全國人口還高。在探討乾癬的死亡風險因子時,我們發現在追蹤小於4年的患者中,嚴重型乾癬的死亡風險沒有升高(Hazard ratio(HR):0.82,95%CI:0.55-1.22);但是在追蹤大於4年的患者中,嚴重型乾癬的死亡風險則是升高(HR:1.83,95%CI:1.18-2.83)。 由以上研究結果可知,乾癬患者的確有比較高的死亡風險,和全國人口比起來,腎臟疾病的死亡風險最高。這些不同的死因和乾癬的關聯性需要進一步的研究來作釐清。另外,嚴重型乾癬是乾癬的死亡風險因子主要是表現在追蹤比較長的患者身上。 | zh_TW |
| dc.description.abstract | Background
Psoriasis is a chronic inflammatory disease which affects 0.19% of Taiwanese population. It has been known that psoriasis is associated with several co-morbidities including obesity, diabetes, cardiovascular disease, cancer and depression. In addition, patients with psoriasis have higher rates of smoking and drinking alcohol. All these co-morbidities may lead to high risks of mortality in patients. So far, several studies related to mortality and psoriasis showed that patients with psoriasis had an increased risk of death. Patients with severe psoriasis were found to have higher risk of death from cardiovascular disease, cancer, liver disease, diabetes and dementia. However, the data related to Asian population is limited. Objectives To describe all-cause and cause-specific mortality in patients with psoriasis and determine the risk for mortality in psoriasis Material and method We perform a hospital-based cohort study from 2001 to 2008 of patients aged of more than 20 years and less than 65 years. Survival status, date of death and cause of death were ascertained by linking the study cohort with the National Register of Deaths Database of Taiwan. All-cause and cause-specific standardized mortality ratios (SMRs) were estimated. Besides, age- and sex-adjusted Cox proportional hazards models were used to determine the risk of mortality. Results We observed 209 deaths in 5940 patients. The all-cause standardized mortality ratio (SMR) was 1.55 (95% confidence interval [CI], 1.35-1.77). In the analysis of causes of death, the SMRs for death due to diabetes( 2.32; 95%CI, 1.46-3.68), cardiovascular disease(2.20 ;95%CI, 1.48-3.29), liver disease (2.74; 95%CI, 1.85-4.05), malignancy (1.34; 95%CI, 1.05-1.73)and kidney disease (3.30, 95%CI: 1.77-6.13) were significantly higher. Severe psoriasis is not associated with mortality in patients who were followed less than 4 years (Hazard ratio:0.82; 95%CI, 0.55-1.22). However, the risk of severe psoriasis increased for mortality in those followed for more than 4 years (HR:1.83; 95%CI, 1.18-2.83). Conclusion The overall mortality among patients with psoriasis was 1.5 times greater than that of the general population. Patients with psoriasis have higher risk of mortality from diabetes, cardiovascular disease, liver disease, malignancy and kidney disease. Severe psoriasis is associated with an increased risk of death in patients who were followed more than 4 years. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:03:39Z (GMT). No. of bitstreams: 1 ntu-100-R98846002-1.pdf: 456806 bytes, checksum: 92d8bd94508ea06da153d52c6ffb8396 (MD5) Previous issue date: 2011 | en |
| dc.description.tableofcontents | 謝辭 I
中文摘要 II 英文摘要 IV 目錄 VI 表目錄 VIII 圖目錄 IX 第一章 研究背景 1 第一節 關於乾癬 1 第二節 乾癬及其共病(co-morbidity) 2 2.1 乾癬和肥胖 2 2.2 乾癬和糖尿病 2 2.3乾癬和高血壓 3 2.4 乾癬和心臟血管疾病 3 2.5 乾癬的免疫機轉及共病 4 第三節 乾癬及死亡研究 4 第四節 嚴重程度在乾癬的重要性 5 4.1 乾癬嚴重程度定義 5 4.2 乾癬嚴重程度與共病 6 4.3 乾癬嚴重程度與死亡研究 6 第二章 研究目的 8 第三章 研究方法 9 第一節 研究設計 9 1.1研究對象的納入條件 9 1.2 研究對象資料收集 9 1.3 死亡及死因分類 9 1.4 資料分析 10 第二節 標準化死亡比(Standardized mortality ratio) 10 2.1標準化死亡比(standardized mortality ratio)的計算 11 第三節 分析乾癬死亡風險因子 12 3.1 乾癬嚴重程度定義 12 3.2 人年的計算 12 3.3 調整共變數 13 3.4 估計樣本數 13 3.5 Kaplan-Meier存活估計(Kaplan-Meier survival estimates) 13 3.6 Cox proportional hazards model(比例風險回歸模型) 13 第四章 結果 16 第一節 標準化死亡率(Standardized mortality ratio) 16 1.1乾癬患者全死因死亡率 16 1.2 乾癬患者特殊死因死亡率 16 第二節 乾癬患者死亡的風險 17 2.1乾癬患者臨床特徵 17 2.2 Kaplan-Meier survival estimates (Kaplan-Meier存活估計) 17 2.3 Cox proportional hazards model(比例風險回歸模型) 18 第五章 討論 19 第一節 本研究主要發現 19 第二節 和之前的文獻比較 19 2.1 乾癬及特殊死因 19 2.2 乾癬嚴重程度及死亡風險 21 第三節 相關生物機轉 22 第四節 臨床應用 23 第五節 strength and weakness 24 參考文獻 25 附錄 | |
| dc.language.iso | zh-TW | |
| dc.subject | 死亡危險因子 | zh_TW |
| dc.subject | 乾癬 | zh_TW |
| dc.subject | 標準化死亡率 | zh_TW |
| dc.subject | 存活分析 | zh_TW |
| dc.subject | risk factors of mortality | en |
| dc.subject | psoriasis | en |
| dc.subject | SMR | en |
| dc.subject | suivaval analysis | en |
| dc.title | 乾癬患者死亡分析及疾病嚴重程度對存活的影響 | zh_TW |
| dc.title | Mortality and Its Relationship to the Disease Severity among Patients with Psoriasis | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 程蘊菁,李文宗,楊志勛,邱顯清 | |
| dc.subject.keyword | 乾癬,標準化死亡率,存活分析,死亡危險因子, | zh_TW |
| dc.subject.keyword | psoriasis,SMR,suivaval analysis,risk factors of mortality, | en |
| dc.relation.page | 48 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2011-07-22 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-100-1.pdf 未授權公開取用 | 446.1 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
